166 related articles for article (PubMed ID: 9089231)
1. Role of non-major histocompatibility complex antigens in the rejection of transplanted myoblasts.
Boulanger A; Asselin I; Roy R; Tremblay JP
Transplantation; 1997 Mar; 63(6):893-9. PubMed ID: 9089231
[TBL] [Abstract][Full Text] [Related]
2. Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin.
Vilquin JT; Wagner E; Kinoshita I; Roy R; Tremblay JP
J Cell Biol; 1995 Nov; 131(4):975-88. PubMed ID: 7490298
[TBL] [Abstract][Full Text] [Related]
3. Increased granzyme B mRNA after alloincompatible myoblast transplantation.
Guérette B; Roy R; Tremblay M; Asselin I; Kinoshita I; Puymirat J; Tremblay JP
Transplantation; 1995 Nov; 60(9):1011-6. PubMed ID: 7491674
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte infiltration following allo- and xenomyoblast transplantation in mdx mice.
Guérette B; Asselin I; Vilquin JT; Roy R; Tremblay JP
Muscle Nerve; 1995 Jan; 18(1):39-51. PubMed ID: 7799997
[TBL] [Abstract][Full Text] [Related]
5. Effect of injecting primary myoblasts versus putative muscle-derived stem cells on mass and force generation in mdx mice.
Mueller GM; O'Day T; Watchko JF; Ontell M
Hum Gene Ther; 2002 Jun; 13(9):1081-90. PubMed ID: 12067441
[TBL] [Abstract][Full Text] [Related]
6. Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or Nk1.1+ cells.
Hodgetts SI; Beilharz MW; Scalzo AA; Grounds MD
Cell Transplant; 2000; 9(4):489-502. PubMed ID: 11038066
[TBL] [Abstract][Full Text] [Related]
7. Extracorporeal circulation as a new experimental pathway for myoblast implantation in mdx mice.
Torrente Y; D'Angelo MG; Del Bo R; DeLiso A; Casati R; Benti R; Corti S; Comi GP; Gerundini P; Anichini A; Scarlato G; Bresolin N
Cell Transplant; 1999; 8(3):247-58. PubMed ID: 10442737
[TBL] [Abstract][Full Text] [Related]
8. Normal myoblast implantation in MDX mice prevents muscle damage by exercise.
Brussee V; Merly F; Tardif F; Tremblay JP
Biochem Biophys Res Commun; 1998 Sep; 250(2):321-7. PubMed ID: 9753628
[TBL] [Abstract][Full Text] [Related]
9. Dystrophin delivery in dystrophin-deficient DMDmdx skeletal muscle by isogenic muscle-derived stem cell transplantation.
Ikezawa M; Cao B; Qu Z; Peng H; Xiao X; Pruchnic R; Kimura S; Miike T; Huard J
Hum Gene Ther; 2003 Nov; 14(16):1535-46. PubMed ID: 14577915
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of increasing dystrophin-positive myofibers by myoblast transplantation: study using mdx/beta-galactosidase transgenic mice.
Kinoshita I; Vilquin JT; Tremblay JP
Acta Neuropathol; 1996; 91(5):489-93. PubMed ID: 8740229
[TBL] [Abstract][Full Text] [Related]
11. Central tolerance to myogenic cell transplants does not include muscle neoantigens.
Camirand G; Stéphan L; Rousseau J; Sackett MK; Caron NJ; Mills P; Kurtz J; Sykes M; Rothstein DM; Tremblay JP
Transplantation; 2008 Jun; 85(12):1791-801. PubMed ID: 18580473
[TBL] [Abstract][Full Text] [Related]
12. Transplantation of human embryonic myoblasts and bone marrow stromal cells into skeletal muscle of C57BL/10J-mdx mice.
Saburina IN; Semenova ML; Goldshtein DV; Tomm NA; Rzhaninova AA; Golichenkov VA; Repin VS
Bull Exp Biol Med; 2004 May; 137(5):521-4. PubMed ID: 15455134
[TBL] [Abstract][Full Text] [Related]
13. Successive injections in mdx mice of myoblasts grown with bFGF.
Kinoshita I; Vilquin JT; Roy R; Tremblay JP
Neuromuscul Disord; 1996 May; 6(3):187-93. PubMed ID: 8784807
[TBL] [Abstract][Full Text] [Related]
14. Improved success of myoblast transplantation in mdx mice by blocking the myostatin signal.
Benabdallah BF; Bouchentouf M; Tremblay JP
Transplantation; 2005 Jun; 79(12):1696-702. PubMed ID: 15973171
[TBL] [Abstract][Full Text] [Related]
15. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells.
Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T
Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791
[TBL] [Abstract][Full Text] [Related]
16. Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy.
Ohtsuka Y; Udaka K; Yamashiro Y; Yagita H; Okumura K
J Immunol; 1998 May; 160(9):4635-40. PubMed ID: 9574572
[TBL] [Abstract][Full Text] [Related]
17. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product.
Yuasa K; Sakamoto M; Miyagoe-Suzuki Y; Tanouchi A; Yamamoto H; Li J; Chamberlain JS; Xiao X; Takeda S
Gene Ther; 2002 Dec; 9(23):1576-88. PubMed ID: 12424610
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.
Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J
Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261
[TBL] [Abstract][Full Text] [Related]
19. Quantification of normal dystrophin mRNA following myoblast transplantation in mdx mice.
Asselin I; Tremblay M; Vilquin JT; Guérette B; Roy R; Tremblay JP
Muscle Nerve; 1995 Sep; 18(9):980-6. PubMed ID: 7643878
[TBL] [Abstract][Full Text] [Related]
20. Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice.
Torrente Y; Tremblay JP; Pisati F; Belicchi M; Rossi B; Sironi M; Fortunato F; El Fahime M; D'Angelo MG; Caron NJ; Constantin G; Paulin D; Scarlato G; Bresolin N
J Cell Biol; 2001 Jan; 152(2):335-48. PubMed ID: 11266450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
